Page last updated: 2024-11-01

ofloxacin and Carotid Artery Diseases

ofloxacin has been researched along with Carotid Artery Diseases in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.

Research Excerpts

ExcerptRelevanceReference
"pneumoniae IgA and/or IgG."2.73Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection. ( Furusyo, N; Hayashi, J; Kikuchi, K; Maeda, S; Ohnishi, H; Sawayama, Y; Tatsukawa, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sawayama, Y1
Tatsukawa, M1
Kikuchi, K1
Maeda, S1
Ohnishi, H1
Furusyo, N1
Hayashi, J1

Trials

1 trial available for ofloxacin and Carotid Artery Diseases

ArticleYear
Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Anticholesteremic Agents; Carotid Arteries; Carotid Artery Diseases; Ch

2007